Hizentra Resources

Use these resources to help you start and maintain Hizentra therapy.

	Hizentra Patient Brochure Your guide to primary immunodeficiency disease and Hizentra, the sub-q (subcutaneous) therapy that fits your life. Order Now
	IgIQ Resource Center Brochure Your guide to IgIQ, a support center that manages Ig product-related information and assists with enrollment in CSL Behring support programs. Order now
	Hizentra Step-by-Step Infusion Guide A reference guide that details the 11 steps for properly infusing Hizentra. Order now
	Hizentra Therapy Journal A 52-week journal that allows you to log your infusions and other important information about your treatment with Hizentra. Order now
	Hizentra Starter Journal A journal designed to help you start Hizentra therapy, log infusions, and keep track of your therapy. Order now
	Self-Administration DVD A DVD that demonstrates how to properly self-administer Hizentra, after training from a healthcare professional. Watch Video now Order now
	Hizentra Patient Starter Kit A box of materials for patients starting Hizentra therapy which includes the Hizentra patient brochure, informational DVD, step by step infusion guide, starter therapy journal and reply card for registration in the Voice2Voice program. Order now
	Adult Therapy Kit A Hizentra starter kit for adults, which includes a travel bag to hold supplies, an infusion placemat, and a 52-week therapy journal. Order now
	Child Therapy Kit A Hizentra starter kit for caregivers of children with PIDD, which includes a travel bag to hold supplies, an infusion placemat, a 52-week therapy journal, a therapeutic play pack, and an "Our Immune System" storybook. Order now
	Treating Primary Immunodeficiency A video discussing the hereditary causes and treatments for PIDD. Download now

Important Safety Information

Immune Globulin Subcutaneous (Human), Hizentra^®, treats various forms of primary immunodeficiency (PI) in patients age 2 and over.

Hizentra should not be used if you have had serious negative reactions to immune globulin (Ig) preparations or a deficiency of an Ig known as IgA. Because Hizentra contains the amino acid proline as stabilizer, patients with hyperprolinemia (too much proline in the blood) should not take Hizentra.

Infuse Hizentra under your skin only; do not inject into a blood vessel.

Allergic reactions can occur with Hizentra. If your doctor suspects you are having a bad allergic reaction or are going into shock, treatment will be discontinued. Immediately tell your doctor or go to the emergency room if you have signs of such a reaction, including hives, trouble breathing, wheezing, dizziness, or fainting.

Tell your doctor about any side effects that concern you. Your doctor will monitor for potentially serious reactions that have been seen with Ig treatment, including thrombotic events (blood clotting); aseptic meningitis syndrome (brain swelling); osmotic nephropathy (a kidney condition); hemolysis (a blood problem) and transfusion-related acute lung injury.

The most common drug-related adverse reactions in the clinical trial for Hizentra were injection-site reactions (swelling, pain, redness, heat or itching); headache; back pain; diarrhea; tiredness; cough; rash; itching; nausea and vomiting.

Hizentra is made from components of human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Vaccines (such as measles, mumps and rubella) might not work as well if you are using Hizentra. Before receiving a vaccination, tell the healthcare professional that you are being treated with Hizentra. Also tell your doctor if you are pregnant or nursing, or if you plan to become pregnant.

You are encouraged to report negative effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Hizentra Resources

Make your Sub-Q transition smooth

Important Safety Information